FAKTOR-VIII-POLYPEPTIDFORMULIERUNGEN

Patent europeic · EP2968477 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2968477
Numer da la dumonda
EP14725816
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
14-03-2014
Publitgà
20-01-2016
Concedì
04-12-2019
La protecziun finescha il pli tard
13-03-2034
Proxima taxa annuala scadenta
31-03-2027
Classas IPC
A61K 38/37 (2006.01)
Prioritad
US 201361800293 P 15.03.2013
US 201361817085 P 29.04.2013
US 201361829884 P 31.05.2013
US 201361839477 P 26.06.2013
US 201361863860 P 08.08.2013
US 201361876927 P 12.09.2013
US 201361879955 P 19.09.2013
US 201361897742 P 30.10.2013
Dumonda PCT
PCT/US2014/029354 14.03.2014
Publicaziun PCT
WO2014/144795 18.09.2014
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-04-2026

    Midada

    Published in Swissreg on 01.04.2026

  2. 01-04-2025

    Midada

    Published in Swissreg on 01.04.2025

  3. 01-04-2024

    Midada

    Published in Swissreg on 01.04.2024

  4. 01-04-2023

    Midada

    Published in Swissreg on 01.04.2023

  5. 04-12-2019

    Concedì

    Published in Swissreg on 04.12.2019

Partidas

Possessur

Bioverativ Therapeutics Inc.

225 Second Avenue, Waltham, MA 02451, US

Inventur

MALONEY, Kevin

Cambridge, Massachusetts 02142, US

GAGE, Daniel

Cambridge, Massachusetts 02142, US

ABDUL-FATTAH, Ahmad

Cambridge, Massachusetts 02142, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.